United States HR 383: To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

Status: Referred to the Subcommittee on Health. (as of 2023-01-27)

State: United States · Session: 118 · Bill: HR 383

Sponsors: Diana Harshbarger, Anna Paulina Luna, Brian J. Mast, CHRISTOPHER H. SMITH, Clay Higgins, Daniel Webster, Doug Lamborn, Earl L. "Buddy" Carter, Glenn Grothman, James R. Baird, Jeff Duncan, Jim Banks, John R. Moolenaar, Kevin Hern, Lauren Boebert, Mary E. Miller, Michael Guest, Mike Bost, Mike Flood, PETE SESSIONS, Paul A. Gosar, ROBERT B. ADERHOLT, Randy Feenstra, Randy K. Weber, Ronny Jackson

View United States HR 383 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.